1. |
殷凱生. 以臨床控制作為防治哮喘的目標. 實用臨床醫藥雜志, 2008, 12, 1-2.
|
2. |
Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med, 2004, 170: 836-844.
|
3. |
O’Byrne PM. Global Strategy for asthma management and prevention [ DB/ CL] . Hamilton; GINA Executive Committee, 2006 [ 2007-7-11] . http: / / www. Ginaasthma. com.
|
4. |
林江濤, 李龍蕓, 陳萍, 等. 吸入布地奈德/ 福莫特羅干粉劑與聯合吸入兩種干粉劑治療支氣管哮喘的療效和安全性研究. 中華結核和呼吸雜志, 2006, 29: 421-423.
|
5. |
劉春濤. 中重度哮喘治療方案的調整. 中國呼吸與危重監護雜志, 2008, 7: 329-331.
|
6. |
Scicchitano R, Aalbers R, Ukena D, et al. Efficacy and safety of budesonide/ formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin,2004, 20: 1403-1418.
|
7. |
周新. 支氣管哮喘控制的評估方法. 中華結核和呼吸雜志,2008, 31: 166-168.
|
8. |
JuniperEF,O’Byrne PM, Guyatt GH, et al. Development and validation of a questinonair to measure asthma control. Eur Respir J, 1999, 14: 902-907.
|
9. |
Barnes PJ. Scientific rationale for using a single inhaler for asthma control. Eur Respir J, 2007, 29: 587-595.
|
10. |
O’Byrne PM, Bisgaard H, Godard PP, et al. Budesonide /formaoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Med, 2005, 171: 129-136.
|
11. |
Rabe KF, Pizzichini E, Stalberg B, et al. Budersonide / formoterol in a inhaler for maintenance and relief in mild to moderate asthma:a randomized, double-blind trial. Chest, 2006, 129: 246-256.
|